ArticleCommunications biology2025
Structure-based modeling and engineering of Corynebacterium glutamicum LysE transporter for efficient extrusion of L-arginine.
Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Metabolic engineering of Corynebacterium glutamicum for high-yield de novo biosynthesis of 5-aminovaleramide, a promising bio-based monomer.Microbial cell factories · 2026Article
- An orthogonal transcription mutation system generating all transition mutations for accelerated protein evolution in vivo.Nature communications · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Transporter engineering is an effective strategy for enhancing the transmembrane transfer of target substrates and alleviating feedback inhibition in microbial cells. The LysE transporter, a key indicator of both L-arginine (L-Arg) and L-lysine (L-Lys) secretion in Corynebacterium glutamicum, plays a crucial role in the efficient synthesis of these amino acids. Owing to its broad substrate specificity, a LysE mutant with high substrate specificity for L-Arg extrusion is essential for achieving high production. In this study, we constructed a structural model and identified that LysE possesses a simplified structure of the characteristic LeuT-fold pattern, including parallel discontinuous helices, three highly conserved motifs, and several critical residues within its substrate binding pocket. Molecular docking and virtual site-saturation mutagenesis identified key hotspot residues for modulating LysE transport activity, with the A156Y and A156V mutants exhibiting significantly enhanced L-Arg extrusion. Iterative saturation mutagenesis at site L49 yielded the A156VL49T mutant, which was characterized by a 32.4% increase in growth under 30 g L
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.